0000950170-24-023437.txt : 20240229
0000950170-24-023437.hdr.sgml : 20240229
20240229194910
ACCESSION NUMBER: 0000950170-24-023437
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Dyne Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818794
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 364883909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 24706348
BUSINESS ADDRESS:
STREET 1: 1560 TRAPELO ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 786-8230
MAIL ADDRESS:
STREET 1: 1560 TRAPELO ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: McNeill Jonathan
CENTRAL INDEX KEY: 0001824673
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O DYNE THERAPEUTICS, INC.
STREET 2: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
144
1
primary_doc.xml
144
0001824673
XXXXXXXX
LIVE
0001818794
Dyne Therapeutics, Inc.
001-39509
1560 Trapelo Road
Waltham
MA
02451
(781)-786-8230
Jonathan McNeill
Officer
Common Stock
Stifel Financial Corporation
3 Bryant Park, 4th Floor
1095 Avenue of the Americas
New York
NY
10036
4268
117382
61375598
02/29/2024
NASDAQ
Common Stock
02/29/2024
Stock option exercise
Issuer
N
4268
02/29/2024
Cash
N
Jonathan McNeill
1560 Trapelo Road
Waltham
MA
02451
Common Stock
12/11/2023
1245
13346
Jonathan McNeill
1560 Trapelo Road
Waltham
MA
02451
Common Stock
01/02/2024
11900
155890
Jonathan McNeill
1560 Trapelo Road
Waltham
MA
02451
Common Stock
01/03/2024
17991
337048
Jonathan McNeill
1560 Trapelo Road
Waltham
MA
02451
Common Stock
01/04/2024
2009
36246
Jonathan McNeill
1560 Trapelo Road
Waltham
MA
02451
Common Stock
01/26/2024
20000
490502
The sales reported in this Form 144 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.
02/29/2024
06/29/2023
/s/ Richard Scalzo, Attorney-in-Fact